Хайлтын үр дүнгүүд - Yanxia He

  • 5-н 1 - 5 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    The First Genetic Map in Sweet Osmanthus (Osmanthus fragrans Lour.) Using Specific Locus Amplified Fragment Sequencing

    The First Genetic Map in Sweet Osmanthus (Osmanthus fragrans Lour.) Using Specific Locus Amplified Fragment Sequencing -н Yanxia He, Wangjun Yuan, Meifang Dong, Yuanji Han, Fude Shang

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation

    FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation -н Shaoqiang Cheng, Yuanxi Huang, Chun Lou, Yanxia He, Yue Zhang, Qingyuan Zhang

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    <i>Retracted:</i> Lnc<scp>RNA </scp><i><scp>THOR</scp></i> increases osteosarcoma cell stemness and migration by enhancing <scp>SOX</scp>9 <scp>mRNA</scp> stability

    <i>Retracted:</i> Lnc<scp>RNA </scp><i><scp>THOR</scp></i> increases osteosarcoma cell stemness and migration by enhancing <scp>SOX</scp>9 <scp>mRNA</scp> stability -н Hao-Jun Wu, Yanxia He, Hang Chen, Yanzhi Liu, Bo Wei, Guanghua Chen, Lin Han, Hao Lin

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma

    VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma -н Haixia He, Yan Gao, Jianchang Fu, Qianghua Zhou, Xiaoxiao Wang, Bing Bai, Pengfei Li, Cheng Huang, Qixiang Rong, Liqin Ping, Yanxia He, Jiaying Mao, Chen Xu, Huiqiang Huang

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study

    Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study -н Yan Gao, Haixia He, Xue‐Ping Li, Liling Zhang, Wei Xu, Ru Feng, W. Li, Xiao Yin, Xinxiu Liu, Yu Chen, Xiaoxiao Wang, Bing Bai, Huijing Wu, Qingqing Cai, Zhiming Li, Jibin Li, Suxia Lin, Yanxia He, Liqin Ping, Cheng Huang, Jiaying Mao, Xiujin Chen, Baitian Zhao, Huiqiang Huang

    Хэвлэсэн 2024
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: